CDK2AP1 and neoplasm: Moreover, by comparing the expression of CDK2AP1 in LIHC samples at different clinical stages and histologic grades, we found that increased expression of CDK2AP1 associated significantly with clinical stage (p < 0.001) and tumor grade (p < 0.001, Figure 1C).